The National ALS Registry, managed by the Center for Disease Control (CDC) is one of the most important weapons in the fight against Amyotrophic Lateral Sclerosis (ALS). At the Annual Surveillance Meeting, Pranger ALS Clinic Director Dr. Stephen Goutman presented an update of important findings funded by the CDC.
At the 31st Annual Meeting of NEURODIAB, Dr. Stephanie Eid was awarded the Angelika Bierhaus prize in basic research .
In honor of World Brain Day, established by the World Federation of Neurology, we wanted to share a selection of brain imaging from our research.
Speaking to the joint Harvard NeuroDiscovery Center and MassGeneral Institute for Neurodegenerative Disease Informatics group, Dr. Feldman discusses the problem of diabetic neuropathy, its causes and treatment, and our lab investigations of this condition.
Dr. Brian Callaghan shares his position about the current problems of diabetic neuropathy testing. He presented this argument during a debate at the American Diabetes Association's 81st Scientific Sessions.
Our collaborator in science Dr. Sunitha Nagrath shares her experiences and advice as a female engineer, from her beginnings in India to her work with us uncovering the secrets of exosomes.
Ever heard of a runner's high? The fourth installment of the NeuroNetwork for Emerging Therapies Mini Symposium Series explores the effects of exercise on the nervous system and brain health.
This marks the first time that Drs. Stephen Goutman and Benjamin Murdock have been awarded an R01 grant by the NIH.
What Causes ALS? National Registry Seeks Answer.
In honor of ALS Awareness Month, the American Neurological Association sat down with Dr. Eva Feldman, a past president of theirs, for a Q&A. Read it here.
Watch Dr. Eva Feldman join Internal Medicine Chair Dr. John Carethers and fellow NeuroNetwork for Emerging Therapies Faculty Drs. Rodica Pop-Busui and Salim Hayek for a webinar on post-COVID care, Long COVID and health disparities.
On World Voice Day, a message from a NeuroNetwork faculty member, Norman D. Hogikyan, M.D., FACS, Director of Michigan Medicine's Vocal Health Center.
Disease Models & Mechanisms selected Sarah Elzinga for a special Q&A about her recently published paper about the sex differences in insulin resistance, but not peripheral neuropathy in diet-induced prediabetes animal models
The NeuoNetwork for Emerging Therapies hosted Doug Wright, Ph.D., Professor of Anatomy and Cell Biology University of Kansas Medical Center for Michigan Medicine Neurology Grand Rounds. The talk was entitled "Non-Pharmacologic Treatments for Diabetic Peripheral Neuropathy."
Early March, Dr. Feldman was invited to be a part of a meeting on "Long COVID" at the National Institutes of Health (NIH). In this video, she shares what she spoke about, what she learned, and what it means for the future of Michigan Medicine COVID-19 research.
At the March 18 symposium, Michigan Medicine lead dietitian Danielle Karsies will discuss the role that nutrition plays in brain health and strategies for selecting what foods to eat to maintain optimal brain function.
Dr. Stephen Goutman, director of the Pranger ALS Clinic, recognizes Rare Disease Day and commends the patients, caregivers, and clinic staff who work together to improve the quality of life for present and future ALS patients.
During the March 18 symposium, Debra Reid, PhD, MA, Curator of Agriculture and the Environment at The Henry Ford, will discuss the history of the American diet and how urban residents obtained fresh fruits and vegetables from urban markets, such as the Central Farmers Market that is under reconstruction at Greenfield Village.
Edith Briskin has established an emerging scholarship and introduced Sarah Elzinga, Ph.D., as the inaugural Edith Briskin Emerging Scholar at the NeuroNetwork for Emerging Therapies.
Matt McKeown, a patient in the Michigan Medicine Pranger ALS Clinic , built his own robot to feed himself. Watch a video of the robot in action and read the feature story about him.
